Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system
延长给药间隔对环境和公共卫生的预期效益:一项针对美国国家卫生系统中帕博利珠单抗使用情况的分析
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(24)00200-6
Bryant, Alex K; Lewy, Jacqueline R; Bressler, R Daniel; Chopra, Zoey; Gyori, Derek J; Bazzell, Brian G; Moeller, Julie A; Jacobson, Sofia I; Fendrick, A Mark; Kerr, Eve A; Ramnath, Nithya; Green, Michael D; Hofer, Timothy P; Vaishnav, Parth; Strohbehn, Garth W